Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
May 3 BDX Becton Dickinson Second Quarter 2024 Earnings: EPS Beats Expectations
May 3 LLY Eli Lilly: Don't Overpay For Miracle Drugs
May 3 BDX Stock Market News for May 3, 2024
May 3 BDX Becton Dickinson & Co (BDX) Q2 2024 Earnings Call Transcript Highlights: Strong Growth and ...
May 3 BDX Q2 2024 Becton Dickinson and Co Earnings Call
May 2 LLY 1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $892. Is It a Buy?
May 2 LLY Analysts reveal Eli Lilly stock price targets after earnings
May 2 LLY Weight Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
May 2 BDX Becton, Dickinson files for automatic mixed securities shelf
May 2 LLY Amgen Soars After CEO Gives Update on Experimental Obesity Drug
May 2 ASND Ascendis Pharma reports Q1 results
May 2 LLY Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK
May 2 LLY Weigh Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
May 2 CORT The Analyst Verdict: Corcept Therapeutics In The Eyes Of 4 Experts
May 2 ASND Ascendis Pharma Reports First Quarter 2024 Financial Results
May 2 LLY Palatin gets FDA OK to test weight loss therapy with Eli Lilly’s tirzepatide
May 2 LLY Earnings Season: 3 Companies Boosting Guidance
May 2 BDX Becton & Dickinson 'Is Well On Its Way To Achieving 2025 Commitments,' Analyst Optimistic On Outlook
May 2 LLY Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
May 2 BDX Becton, Dickinson and Company (BDX) Q2 2024 Earnings Call Transcript
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags